17 completed, 3 unknown, 1 terminated. 7 Phase 3, 6 Phase 4, 4 Phase 2, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 6, Unknown 1 |
| Phase 4 | 6 | Completed 5, Unknown 1 |
| Phase 2 | 4 | Completed 4 |
| Not applicable | 2 | Terminated 1, Unknown 1 |
Follow voglibose: new trials by email Literature Review of voglibose trials Research Report on voglibose
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Glycaemic & Cardiovascular Treatment Outcomes of Voglibose Vs Glibenclamide Added to Metformin in T2DM Patients Voglibose + Metformin, Glibenclamide + Metformin - Diabetes Mellitus Type 2 Without Complication | Phase 3 | Unknown | University of Zambia | 118 | 2023-08-01 | 2023-07-03 |
| Efficacy and Safety of Voglibose Compared With Acarbose in Participants With Type 2 Diabetes Metformin, Voglibose, Acarbose - Type 2 Diabetes Mellitus | Phase 4 | Completed | Takeda | 494 | 2014-05-09 | 2019-03-13 |
| Incretin-based Drugs and the Risk of Heart Failure DPP-4 inhibitors, GLP-1 analogs, Insulins - Type 2 Diabetes Mellitus | Completed | Canadian Network for Observational Drug Effect Studies, CNODES | 1499650 | 2014-03-01 | 2016-04-19 | |
| Incretin-based Drugs and Acute Pancreatitis DPP-4 inhibitors, GLP-1 analogs, Insulins - Diabetes Mellitus, Type 2 | Completed | Canadian Network for Observational Drug Effect Studies, CNODES | 1417914 | 2014-03-01 | 2016-11-03 | |
| Incretin-based Drugs and Pancreatic Cancer DPP-4 inhibitors, GLP-1 analogs, Sulfonylureas - Diabetes Mellitus, Type 2 | Completed | Canadian Network for Observational Drug Effect Studies, CNODES | 886172 | 2014-03-01 | 2016-03-14 | |
| Effect of Linagliptin on Insulin Sensitivity and Pancreatic Beta Cell Function in Patients With Type 2 Diabetes Mellitus Linagliptin, Placebo, Voglibose - Type 2 Diabetes Mellitus, Insulin Sensitivity/Resistance | Phase 4 | Unknown | Post Graduate Institute of Medical Education and Research, Chandigarh | 30 | 2013-12-01 | 2014-04-08 |
| Drug Interaction of Vildagliptin (LAF237) With Voglibose in Japanese Patients With Type 2 Diabetes Vildagliptin (LAF237), Voglibose, Vildagliptin and Voglibose - Type 2 Diabetes | Phase 4 | Completed | Novartis Pharmaceuticals | 24 | 2011-02-01 | 2020-12-19 |
| A Study to Assess the Safety and Efficacy of ASP1941 in Combination With α-glucosidase Inhibitor in Type 2 Diabetic Patients ipragliflozin, alpha glucosidase inhibitor - Type 2 Diabetes Mellitus | Phase 3 | Completed | Astellas Pharma Inc | 113 | 2010-10-21 | 2025-05-30 |
| Postmarketing Clinical Study on AO-128 AO-128 - Impaired Glucose Tolerance (IGT) | Phase 4 | Completed | Takeda | 197 | 2010-03-01 | 2015-04-09 |
| Voglibose Tablets 0.2 / OD Tablets 0.2 Special Drug Use Surveillance "Long-term Use in Patients With Impaired Glucose Tolerance" Voglibose - Impaired Glucose Tolerance | Completed | Takeda | 742 | 2009-11-18 | 2018-12-04 | |
| Glucose Reduction by Early Acarbose Treatment in Basal Insulin Acarbose (Glucobay, BAYG5421), Voglibose (Basen) - Diabetes Mellitus, Type 2 | Phase 4 | Completed | Bayer | 124 | 2009-11-01 | 2014-02-20 |
| MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104) Comparator: Placebo, Sitagliptin, Voglibose - Diabetes Mellitus, Non-Insulin-Dependent | Phase 3 | Completed | Merck Sharp & Dohme LLC | 133 | 2009-02-05 | 2017-05-15 |
| Evaluation of Intervention on Impaired Glucose Tolerance(IGT) in Patients With Coronary Heart Disease. Voglibose tablets - Coronary Heart Disease, Impaired Glucose Tolerance | Not applicable | Unknown | Ministry of Science and Technology of the People´s Republic of China | 1600 | 2008-07-01 | 2008-08-25 |
| Japanese P III vs Voglibose and Placebo BI 1356, voglibose placebo, BI 1356 placebo - Diabetes Mellitus, Type 2 | Phase 3 | Completed | Boehringer Ingelheim | 561 | 2008-04-01 | 2014-01-27 |
| Glufast On Insulin Glargine Trial in Type 2 DM Mitiglinide, Voglibose - Diabetes Mellitus, Type 2 | Phase 4 | Completed | JW Pharmaceutical | 167 | 2008-02-01 | 2012-03-30 |
| Long-term Safety Study of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan Alogliptin and voglibose - Type 2 Diabetes Mellitus | Phase 2 / Phase 3 | Completed | Takeda | 179 | 2007-06-01 | 2012-02-03 |
| Long-term Safety Study of Alogliptin in Participants With Type 2 Diabetes in Japan Alogliptin, Voglibose - Type 2 Diabetes Mellitus | Phase 2 | Completed | Takeda | 438 | 2007-05-01 | 2012-02-03 |
| Efficacy and Safety of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan Alogliptin and voglibose, Voglibose - Type 2 Diabetes Mellitus | Phase 2 / Phase 3 | Completed | Takeda | 230 | 2007-01-01 | 2012-02-03 |
| Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes in Japan Alogliptin, Voglibose, Placebo - Diabetes Mellitus, Type 2 | Phase 2 | Completed | Takeda | 480 | 2007-01-01 | 2012-02-03 |
| A Study of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/Exercise Therapy (0431-054)(COMPLETED) sitagliptin phosphate, Comparator: voglibose - Diabetes Mellitus, Non-Insulin-Dependent | Phase 3 | Completed | Merck Sharp & Dohme LLC | 319 | 2007-01-01 | 2016-02-05 |
Showing 20 of 21. Sign in to see all of them.
Diabetes Mellitus, Type 2 (16) · Diabetes Mellitus (5) · Glucose Intolerance (4) · Coronary Disease (1) · Heart Failure (1) · Insulin Resistance (1) · Myocardial Infarction (1) · Pancreatic Neoplasms (1) · Pancreatitis (1)
Takeda (7) · Canadian Network for Observational Drug Effect Studies, CNODES (3) · Merck Sharp & Dohme LLC (2) · Astellas Pharma Inc (1) · Bayer (1) · Boehringer Ingelheim (1) · JW Pharmaceutical (1) · Ministry of Science and Technology of the People´s Republic of China (1) · National Cerebral and Cardiovascular Center, Japan (1) · Novartis Pharmaceuticals (1) · Post Graduate Institute of Medical Education and Research, Chandigarh (1) · University of Zambia (1)
Japan (6) · Canada (3) · China (2) · South Korea (2) · India (1)
Pierre Ernst, MD, MSc (3) · Kun-ho Yoon (1) · Masafumi Kitakaze, MD, PhD (1) · Wenhui Ding, Professor (1)
PMID 22106975, PMID 19732457, PMID 20590736, PMID 22234149, PMID 23782587, PMID 24431911, PMID 24843714, PMID 26411328, PMID 26888382, PMID 27007958, PMID 27479930, PMID 28779371, PMID 29970184